| Mark M Wehrman, DMD | |
|
220 Thomas More Pkwy, Crestview Hills, KY 41017-3424 | |
| (859) 341-3012 | |
| (859) 341-3013 |
| Full Name | Mark M Wehrman |
|---|---|
| Gender | Male |
| Speciality | Dentist - Pediatric Dentistry |
| Location | 220 Thomas More Pkwy, Crestview Hills, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023210226 | NPI | - | NPPES |
| 61942561 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 4287 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark M Wehrman, DMD 220 Thomas More Pkwy, Crestview Hills, KY 41017-3424 Ph: (859) 341-3012 | Mark M Wehrman, DMD 220 Thomas More Pkwy, Crestview Hills, KY 41017-3424 Ph: (859) 341-3012 |
News Archive
About 10 percent of lung cancers in the United States and as many as 40 percent in Asia are driven by mutations in the EGFR gene.
Jackson, Mich., resident Terrence Hicks and Detroit residents Muhammed Al Mahdi and John Saunders pleaded guilty in U.S. District Court in the Eastern District of Michigan this week for their roles in a $4.2 million Medicare fraud scheme, Assistant Attorney General Lanny A. Breuer of the Criminal Division, Acting U.S. Attorney Terrence Berg of the Eastern District of Michigan, Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office and Daniel R. Levinson, Inspector General of the Department of Health and Human Services (HHS) announced today.
ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.
PuraMed BioScience, announced today that a clinical study of LipiGesic M has been completed. The study design was a double blind, placebo controlled, multi-site study measuring the effectiveness of LipiGesic™ M for the treatment of acute migraine attacks. The next steps include completion of the manuscript, submission for publication in a peer-reviewed medical journal and actual publication. In an effort to maximize the potential for publication, an embargo has been placed on the disclosure of any of the results of this study.
› Verified 1 days ago
Dr. Daniel Joseph Beiting Sr., D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2617 Legends Way, Suite 200, Crestview Hills, KY 41017 Phone: 859-341-2234 Fax: 859-341-4544 | |
Laura Marie Doss, DDS Dentist Medicare: Medicare Enrolled Practice Location: 220 Thomas More Pkwy, Crestview Hills, KY 41017 Phone: 859-341-3012 | |
Kelly Wiechart, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 599 Freedom Park Dr Ste 100, Crestview Hills, KY 41017 Phone: 859-426-0304 | |
David C Quast, D.M.D.,M.S.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 320 Thomas More Pkwy, Crestview Hills, KY 41017 Phone: 859-341-9400 | |
Dr. Mark Andrew Knibbe, MD DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 330 Thomas More Pkwy, Suite 101, Crestview Hills, KY 41017 Phone: 859-578-9000 Fax: 859-578-9815 | |
Dr. Katherine K Beiting, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2617 Legends Way, Suite 200, Crestview Hills, KY 41017 Phone: 859-341-2234 Fax: 859-341-4544 |